Abnormal expression of the cytoskeletal protein dystrophin has deleterious consequences for skeletal muscle, cardiac muscle, and the central nervous system. A complete failure to express the protein produces Duchenne muscular dystrophy (DMD), in which there is extensive and progressive skeletal muscle necrosis, the development of a life-threatening dilated cardiomyopathy, and mild mental retardation. Dystrophin binds the F-actin cytoskeleton and is normally expressed in a complex of transmembrane proteins (the ''dystrophin protein complex'') that interact with external components of the basal lamina. One pathogenic model for DMD (the ''structural hypothesis'') suggests that this complex forms a structural bridge between the external basal lamina and the internal cytoskeleton and that the absence of dystrophin produces a defect in membrane structural support that renders skeletal muscle susceptible to plasmalemmal ruptures (or ''tears'') during the course of contractile activity. This review attempts to critically evaluate the structural hypothesis for DMD and presents an opposing model (the ''channel aggregation model'') that highlights the role of dystrophin in organizing the membrane cytoskeleton and the role of the cytoskeleton in aggregating ion channels and neurotransmitter receptors. Since ion channel aggregation is a process that is common across organ systems, the idea that channel function can be altered when aggregated ion channels interact with a dystrophic cytoskeleton has immediate implications for the expression of the dystrophinopathies in skeletal muscle, cardiac muscle, and the central nervous system. 1998 Academic Press
THE CYTOSKELETAL LOCALIZATION OF THE DYSTROPHIC MOLECULE
Duchenne muscular dystrophy (DMD) results from the absence of dystrophin (Hoffman et al., 1987) , a high-molecular-weight, rod-shaped protein with domains that are homologous to spectrin and ␣-actinin (Koenig & Kunkel, 1989; Koenig et al., 1988) . In nondystrophic muscle, the N-terminal region of dystrophin binds the F-actin cytoskeleton (Ervasti & Campbell, 1991; Levine et al., 1992) , while the C terminus, a region homologous to the autosomal ''dystrophin-related protein' ' (utrophin; Love et al., 1989) , interacts with a transmembrane complex of dystrophin-associated proteins that connects the intracellular dystrophin-actin cytoskeleton with the extracellular matrix composed of laminin, fibronectin, and a variety of other signal transduction agonists (Ervasti & Campbell, 1991; Matsumura & Campbell, 1994) . One of these agonists, agrin, induces the aggregation of acetylcholine receptors (AChRs) (Wallace, 1986 ) by binding to a particular dystrophin-associated protein (␣-dystroglycan) that colocalizes with utrophin and with AChR aggregates (Campanelli et al., 1994; Gee et al., 1994) . Both dystrophin and utrophin are concentrated at mature neuromuscular endplates (Cartaud et al., 1992; Huard et al., 1992; Ohlendieck et al., 1991; Takemitsu et al., 1991) ; utrophin is more closely associated with the endplate AChRs located at the crests of the junctional folds, while dystrophin is more closely apposed to the Neurobiology of Disease 5, 3-15 (1998) Article No. NB980188
